Factors Associated with Large Renal Function Decline in Patients with Chronic Hepatitis C Successfully Treated with Direct-Acting Antiviral Therapy

The findings regarding changes in renal function in patients with hepatitis C virus (HCV) infection treated with direct-acting antivirals (DAAs) are controversial. This study attempted to identify the factors associated with the large decline in renal function following DAA treatment. This retrospec...

Full description

Bibliographic Details
Main Authors: Chun-Hsien Chen, Chien-Heng Shen, Kuo-Liang Wei, Huang-Wei Xu, Wei-Ming Chen, Kao-Chi Chang, Yu-Ting Huang, Yung-Yu Hsieh, Sheng-Nan Lu, Chao-Hung Hung, Te-Sheng Chang
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/13/3/473
_version_ 1797624795447164928
author Chun-Hsien Chen
Chien-Heng Shen
Kuo-Liang Wei
Huang-Wei Xu
Wei-Ming Chen
Kao-Chi Chang
Yu-Ting Huang
Yung-Yu Hsieh
Sheng-Nan Lu
Chao-Hung Hung
Te-Sheng Chang
author_facet Chun-Hsien Chen
Chien-Heng Shen
Kuo-Liang Wei
Huang-Wei Xu
Wei-Ming Chen
Kao-Chi Chang
Yu-Ting Huang
Yung-Yu Hsieh
Sheng-Nan Lu
Chao-Hung Hung
Te-Sheng Chang
author_sort Chun-Hsien Chen
collection DOAJ
description The findings regarding changes in renal function in patients with hepatitis C virus (HCV) infection treated with direct-acting antivirals (DAAs) are controversial. This study attempted to identify the factors associated with the large decline in renal function following DAA treatment. This retrospective cohort study included patients treated with DAAs at Chiayi and Yunlin Chang Gung Hospitals, Taiwan, from 1 January 2017 to 31 October 2020. Estimated glomerular filtration rate (eGFR) data were collected within 90 days prior to DAA therapy and 2 years after the confirmation of a sustained virologic response (SVR). We performed multiple logistic regression to evaluate the clinical or laboratory parameters associated with a large eGFR decline (≥10%). Among the enrolled 606 patients, the mean eGFR at the baseline and endpoint were 84.11 ± 24.38 and 78.88 ± 26.30 mL/min/1.73 m<sup>2</sup>, respectively (<i>p</i> < 0.001). The factors associated with a large eGFR decline 2 years after the SVR included hypertension (OR: 1.481; 95% CI: 1.010–2.173, <i>p</i> = 0.044) and a higher baseline eGFR (OR: 1.016; 95% CI: 1.007–1.024, <i>p</i> < 0.001). A higher albumin level reduced the risk of a large eGFR decline (OR: 0.546; 95% CI: 0.342–0.872, <i>p</i> = 0.011). In the patients with HCV treated with DAAs, a larger renal function decline was more commonly observed in those with hypertension, a lower (but within normal range) albumin level, and a higher baseline eGFR, while DAA treatment had no effect. The clinical significance of these findings has to be further defined. Although some risk factors associated with chronic kidney disease may be alleviated after DAA treatment, the regular control and follow-up of risk factors and renal function are still recommended in at-risk patients after HCV eradication.
first_indexed 2024-03-11T09:47:37Z
format Article
id doaj.art-0ec09dafb59745aaaaea06700fc8f38d
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-11T09:47:37Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-0ec09dafb59745aaaaea06700fc8f38d2023-11-16T16:25:13ZengMDPI AGDiagnostics2075-44182023-01-0113347310.3390/diagnostics13030473Factors Associated with Large Renal Function Decline in Patients with Chronic Hepatitis C Successfully Treated with Direct-Acting Antiviral TherapyChun-Hsien Chen0Chien-Heng Shen1Kuo-Liang Wei2Huang-Wei Xu3Wei-Ming Chen4Kao-Chi Chang5Yu-Ting Huang6Yung-Yu Hsieh7Sheng-Nan Lu8Chao-Hung Hung9Te-Sheng Chang10Division of Gastroenterology and Hepatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi 613, TaiwanDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi 613, TaiwanDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi 613, TaiwanDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi 613, TaiwanDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi 613, TaiwanDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi 613, TaiwanDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi 613, TaiwanDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi 613, TaiwanDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi 613, TaiwanDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi 613, TaiwanDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi 613, TaiwanThe findings regarding changes in renal function in patients with hepatitis C virus (HCV) infection treated with direct-acting antivirals (DAAs) are controversial. This study attempted to identify the factors associated with the large decline in renal function following DAA treatment. This retrospective cohort study included patients treated with DAAs at Chiayi and Yunlin Chang Gung Hospitals, Taiwan, from 1 January 2017 to 31 October 2020. Estimated glomerular filtration rate (eGFR) data were collected within 90 days prior to DAA therapy and 2 years after the confirmation of a sustained virologic response (SVR). We performed multiple logistic regression to evaluate the clinical or laboratory parameters associated with a large eGFR decline (≥10%). Among the enrolled 606 patients, the mean eGFR at the baseline and endpoint were 84.11 ± 24.38 and 78.88 ± 26.30 mL/min/1.73 m<sup>2</sup>, respectively (<i>p</i> < 0.001). The factors associated with a large eGFR decline 2 years after the SVR included hypertension (OR: 1.481; 95% CI: 1.010–2.173, <i>p</i> = 0.044) and a higher baseline eGFR (OR: 1.016; 95% CI: 1.007–1.024, <i>p</i> < 0.001). A higher albumin level reduced the risk of a large eGFR decline (OR: 0.546; 95% CI: 0.342–0.872, <i>p</i> = 0.011). In the patients with HCV treated with DAAs, a larger renal function decline was more commonly observed in those with hypertension, a lower (but within normal range) albumin level, and a higher baseline eGFR, while DAA treatment had no effect. The clinical significance of these findings has to be further defined. Although some risk factors associated with chronic kidney disease may be alleviated after DAA treatment, the regular control and follow-up of risk factors and renal function are still recommended in at-risk patients after HCV eradication.https://www.mdpi.com/2075-4418/13/3/473HCVdirect-acting antiviral therapysustained virologic responserenal function
spellingShingle Chun-Hsien Chen
Chien-Heng Shen
Kuo-Liang Wei
Huang-Wei Xu
Wei-Ming Chen
Kao-Chi Chang
Yu-Ting Huang
Yung-Yu Hsieh
Sheng-Nan Lu
Chao-Hung Hung
Te-Sheng Chang
Factors Associated with Large Renal Function Decline in Patients with Chronic Hepatitis C Successfully Treated with Direct-Acting Antiviral Therapy
Diagnostics
HCV
direct-acting antiviral therapy
sustained virologic response
renal function
title Factors Associated with Large Renal Function Decline in Patients with Chronic Hepatitis C Successfully Treated with Direct-Acting Antiviral Therapy
title_full Factors Associated with Large Renal Function Decline in Patients with Chronic Hepatitis C Successfully Treated with Direct-Acting Antiviral Therapy
title_fullStr Factors Associated with Large Renal Function Decline in Patients with Chronic Hepatitis C Successfully Treated with Direct-Acting Antiviral Therapy
title_full_unstemmed Factors Associated with Large Renal Function Decline in Patients with Chronic Hepatitis C Successfully Treated with Direct-Acting Antiviral Therapy
title_short Factors Associated with Large Renal Function Decline in Patients with Chronic Hepatitis C Successfully Treated with Direct-Acting Antiviral Therapy
title_sort factors associated with large renal function decline in patients with chronic hepatitis c successfully treated with direct acting antiviral therapy
topic HCV
direct-acting antiviral therapy
sustained virologic response
renal function
url https://www.mdpi.com/2075-4418/13/3/473
work_keys_str_mv AT chunhsienchen factorsassociatedwithlargerenalfunctiondeclineinpatientswithchronichepatitiscsuccessfullytreatedwithdirectactingantiviraltherapy
AT chienhengshen factorsassociatedwithlargerenalfunctiondeclineinpatientswithchronichepatitiscsuccessfullytreatedwithdirectactingantiviraltherapy
AT kuoliangwei factorsassociatedwithlargerenalfunctiondeclineinpatientswithchronichepatitiscsuccessfullytreatedwithdirectactingantiviraltherapy
AT huangweixu factorsassociatedwithlargerenalfunctiondeclineinpatientswithchronichepatitiscsuccessfullytreatedwithdirectactingantiviraltherapy
AT weimingchen factorsassociatedwithlargerenalfunctiondeclineinpatientswithchronichepatitiscsuccessfullytreatedwithdirectactingantiviraltherapy
AT kaochichang factorsassociatedwithlargerenalfunctiondeclineinpatientswithchronichepatitiscsuccessfullytreatedwithdirectactingantiviraltherapy
AT yutinghuang factorsassociatedwithlargerenalfunctiondeclineinpatientswithchronichepatitiscsuccessfullytreatedwithdirectactingantiviraltherapy
AT yungyuhsieh factorsassociatedwithlargerenalfunctiondeclineinpatientswithchronichepatitiscsuccessfullytreatedwithdirectactingantiviraltherapy
AT shengnanlu factorsassociatedwithlargerenalfunctiondeclineinpatientswithchronichepatitiscsuccessfullytreatedwithdirectactingantiviraltherapy
AT chaohunghung factorsassociatedwithlargerenalfunctiondeclineinpatientswithchronichepatitiscsuccessfullytreatedwithdirectactingantiviraltherapy
AT teshengchang factorsassociatedwithlargerenalfunctiondeclineinpatientswithchronichepatitiscsuccessfullytreatedwithdirectactingantiviraltherapy